Middle East Healthcare Company vs HCA Healthcare, Inc.
A head-to-head of Middle East Healthcare Company (4009) and HCA Healthcare, Inc. (HCA) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | 4009 | HCA |
|---|---|---|
| Market Cap | 3.13B SAR | $82.34B |
| P/E (TTM) | 9.71 | 12.76 |
| Forward P/E | 8.52 | 13.11 |
| P/S | 1.00 | 1.26 |
| P/B | 1.54 | -16.19 |
| EV/EBITDA | — | 9.68 |
| Dividend Yield | 1.47% | 0.83% |
| Profit Margin | 5.34% | 8.89% |
| Gross Margin | 37.39% | 41.50% |
| Operating Margin | 12.67% | 15.83% |
| Revenue Growth (YoY) | +4.29% | +4.30% |
| FCF Yield | 9.73% | 8.22% |
| Debt / Equity | 123.07 | — |
| Current Ratio | 1.48 | 0.83 |
Which is better: Middle East Healthcare Company or HCA Healthcare, Inc.?
- ✓Larger by market cap: HCA Healthcare, Inc.
- ✓Cheaper valuation (lower P/E): Middle East Healthcare Company
- ✓Higher dividend yield: Middle East Healthcare Company
- ✓More profitable (net margin): HCA Healthcare, Inc.
- ✓Faster revenue growth: HCA Healthcare, Inc.
- ✓Higher free-cash-flow yield: Middle East Healthcare Company
Across 10 available metrics, Middle East Healthcare Company leads 6–4.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
Compare Middle East Healthcare Company with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.